Cargando…
Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure
This study measures the increment of health care expenditure (HCE) that can be attributed to technological progress and change in medical practice by using a residual approach and microdata. We examine repeated cross‐sections of individuals experiencing an initial health shock at different point in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314678/ https://www.ncbi.nlm.nih.gov/pubmed/35362244 http://dx.doi.org/10.1002/hec.4500 |
_version_ | 1784754375086833664 |
---|---|
author | Laudicella, Mauro Li Donni, Paolo Olsen, Kim Rose Gyrd‐Hansen, Dorte |
author_facet | Laudicella, Mauro Li Donni, Paolo Olsen, Kim Rose Gyrd‐Hansen, Dorte |
author_sort | Laudicella, Mauro |
collection | PubMed |
description | This study measures the increment of health care expenditure (HCE) that can be attributed to technological progress and change in medical practice by using a residual approach and microdata. We examine repeated cross‐sections of individuals experiencing an initial health shock at different point in time over a 10‐year window and capture the impact of unobservable technology and medical practice to which they are exposed after allowing for differences in health and socioeconomic characteristics. We decompose the residual increment in the part that is due to the effect of delaying time to death, that is, individuals surviving longer after a health shock and thus contributing longer to the demand of care, and the part that is due to increasing intensity of resource use, that is, the basket of services becoming more expensive to allow for the cost of innovation. We use data from the Danish National Health System that offers universal coverage and is free of charge at the point of access. We find that technological progress and change in medical practice can explain about 60% of the increment of HCE, in line with macroeconomic studies that traditionally investigate this subject. |
format | Online Article Text |
id | pubmed-9314678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93146782022-07-30 Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure Laudicella, Mauro Li Donni, Paolo Olsen, Kim Rose Gyrd‐Hansen, Dorte Health Econ Research Articles This study measures the increment of health care expenditure (HCE) that can be attributed to technological progress and change in medical practice by using a residual approach and microdata. We examine repeated cross‐sections of individuals experiencing an initial health shock at different point in time over a 10‐year window and capture the impact of unobservable technology and medical practice to which they are exposed after allowing for differences in health and socioeconomic characteristics. We decompose the residual increment in the part that is due to the effect of delaying time to death, that is, individuals surviving longer after a health shock and thus contributing longer to the demand of care, and the part that is due to increasing intensity of resource use, that is, the basket of services becoming more expensive to allow for the cost of innovation. We use data from the Danish National Health System that offers universal coverage and is free of charge at the point of access. We find that technological progress and change in medical practice can explain about 60% of the increment of HCE, in line with macroeconomic studies that traditionally investigate this subject. John Wiley and Sons Inc. 2022-03-31 2022-06 /pmc/articles/PMC9314678/ /pubmed/35362244 http://dx.doi.org/10.1002/hec.4500 Text en © 2022 The Authors. Health Economics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Laudicella, Mauro Li Donni, Paolo Olsen, Kim Rose Gyrd‐Hansen, Dorte Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure |
title | Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure |
title_full | Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure |
title_fullStr | Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure |
title_full_unstemmed | Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure |
title_short | Age, morbidity, or something else? A residual approach using microdata to measure the impact of technological progress on health care expenditure |
title_sort | age, morbidity, or something else? a residual approach using microdata to measure the impact of technological progress on health care expenditure |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314678/ https://www.ncbi.nlm.nih.gov/pubmed/35362244 http://dx.doi.org/10.1002/hec.4500 |
work_keys_str_mv | AT laudicellamauro agemorbidityorsomethingelsearesidualapproachusingmicrodatatomeasuretheimpactoftechnologicalprogressonhealthcareexpenditure AT lidonnipaolo agemorbidityorsomethingelsearesidualapproachusingmicrodatatomeasuretheimpactoftechnologicalprogressonhealthcareexpenditure AT olsenkimrose agemorbidityorsomethingelsearesidualapproachusingmicrodatatomeasuretheimpactoftechnologicalprogressonhealthcareexpenditure AT gyrdhansendorte agemorbidityorsomethingelsearesidualapproachusingmicrodatatomeasuretheimpactoftechnologicalprogressonhealthcareexpenditure |